EnerSys (ENS) Stock News

The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. following a short seller report by Hunterbrook alleging the nursing home operator's business model relies on inadequate patient care, understaffing, and misuse of taxpayer funds. The allegations caused Ensign's stock to fall 8.15% on June 8, 2026. Investors who suffered losses are encouraged to join a prospective class action lawsuit.

The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. following a short-seller report by Hunterbrook alleging the nursing home operator engaged in poor patient care and quality metric manipulation. The report claimed company profits depended on understaffing and misappropriation of funds to executives, resulting in patient suffering and deaths. Ensign's stock declined 8.15% on June 8, 2026, following the disclosure.

The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. following a short seller report by Hunterbrook alleging the nursing home operator's business model relies on inadequate patient care, understaffing, and misrouting of funds. Ensign's stock fell 8.15% on June 8, 2026, following the report's publication. The firm is preparing a class action lawsuit to recover investor losses.

The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. following a short seller report by Hunterbrook alleging the nursing home operator's business model relies on inadequate patient care, understaffing, and misrouting of taxpayer funds to executives. Ensign shares fell 8.15% on June 8, 2026, following the report's publication. The firm is preparing a class action lawsuit to recover investor losses.

Rosen Law Firm is investigating The Ensign Group, Inc. (NASDAQ: ENSG) for potentially issuing materially misleading business information to investors. The investigation was triggered by a short-seller report from Hunterbrook alleging that Ensign's profitability model relies on reducing patient care quality and manipulating quality scores. Following the report's release on June 8, 2026, Ensign's stock price declined 8.15%. The firm is preparing a class action lawsuit and inviting affected investors to join.

The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. following a short seller report by Hunterbrook alleging the nursing home operator's business model relies on inadequate patient care, understaffing, and misrouting of funds. Ensign shares fell 8.15% on June 8, 2026, following the report's publication. The firm is preparing a class action lawsuit to recover investor losses.

Pomerantz LLP is investigating The Ensign Group for potential securities fraud following short reports from Hunterbrook and Muddy Waters Research alleging inadequate patient care, understaffing, quality metric manipulation, and possible Medicare/Medicaid fraud. The allegations triggered significant stock price declines of 8.15% and 2.98% on consecutive trading days in June 2026.

Eva Live Inc. (NASDAQ: GOAI) announced a Letter of Intent to acquire a controlling 51% interest in Airbeam Wireless Technologies for approximately $16 million, with an option to acquire the remaining 49%. The acquisition provides access to over 260 patents and advanced millimeter-wave semiconductor technology built on more than $150 million in cumulative R&D investment. Eva Live aims to combine Airbeam's wireless technology with its AI platform to develop next-generation communications for autonomous drone swarms, resilient military networks, smart cities, and satellite infrastructure, targeting a $3 trillion global opportunity.

Law firm Lowey Dannenberg is investigating The Ensign Group for potential federal securities law violations following short-seller reports alleging systemic quality-measure gaming, falsified care-quality data, improper related-party billing, and possible Medicare/Medicaid fraud. The allegations caused significant stock price declines and shareholder losses.

The Rosen Law Firm is investigating potential securities claims against Ensign Group, Inc. following a short seller report by Hunterbrook alleging the nursing home operator's business model relies on inadequate patient care and gaming quality metrics. The report claims profits depend on understaffing facilities while routing taxpayer dollars to executives. Ensign shares fell 8.15% on June 8, 2026, following the report's publication.

Pomerantz LLP is investigating The Ensign Group for potential securities fraud following short reports from Hunterbrook and Muddy Waters Research alleging inadequate patient care, understaffing, quality metric manipulation, and possible Medicare/Medicaid fraud. The allegations triggered significant stock price declines of 8.15% and 2.98% on consecutive trading days in June 2026.

Law firm Robbins Geller Rudman & Dowd LLP has launched an investigation into The Ensign Group, Inc. following a Muddy Waters Research report alleging deception at approximately 20% of facilities with potential multi-billion dollar liability. The report triggered a decline in Ensign's stock price. The firm is seeking investors and witnesses with information about potential federal securities law violations.

The Ensign Group (ENSG) stock fell over 8% after Hunterbrook Media and Muddy Waters Research published critical reports alleging the company cuts staff at acquired nursing facilities while claiming quality improvements, and potentially engages in fraudulent practices involving rented nursing home administrator licenses. The allegations have wiped out over $500 million in market capitalization, prompting Hagens Berman to investigate potential securities law violations.

The Rosen Law Firm is investigating potential securities claims on behalf of Ensign Group shareholders following a short seller report by Hunterbrook alleging the nursing home operator's business model relies on inadequate patient care and gaming quality metrics. The allegations claim profits depend on understaffing facilities while routing taxpayer dollars to executives. Ensign shares fell 8.15% on June 8, 2026, following the report's publication.

Lowey Dannenberg P.C. is investigating The Ensign Group (NASDAQ: ENSG) for potential violations of federal securities laws following short-seller reports alleging systemic quality-measure gaming, falsified care-quality data, improper related-party billing, and possible Medicare/Medicaid fraud. The allegations caused significant stock price declines and shareholder losses.

A securities litigation law firm is investigating The Ensign Group, Inc. for potential federal securities law violations following a report alleging chronic understaffing at nursing facilities, inadequate patient care, document falsification, and improper billing practices. The company's stock fell over 8% following the allegations.

Law firm Lowey Dannenberg is investigating The Ensign Group (NASDAQ: ENSG) for potential federal securities violations following short-seller reports alleging systemic quality-measure gaming, falsified care-quality data, improper related-party billing, and possible Medicare/Medicaid fraud. The allegations caused significant stock price declines and shareholder losses.

The Ensign Group (ENSG) stock fell over 8% after Hunterbrook Media and Muddy Waters Research published critical reports alleging the company cuts staff at acquired nursing facilities while claiming quality improvements, and potentially engages in fraudulent practices involving rented NHA licenses. The allegations have wiped out over $500 million in market capitalization, prompting Hagens Berman to investigate potential securities law violations.

The Rosen Law Firm has announced an investigation into potential securities claims against The Ensign Group, Inc. following a short seller report by Hunterbrook alleging the nursing home operator's business model relies on inadequate patient care, understaffing, and gaming quality metrics. The allegations claim patients have suffered and died as a result, causing Ensign shares to fall sharply on June 8, 2026.

Pomerantz LLP is investigating The Ensign Group for potential securities fraud following a Hunterbrook short report alleging inadequate patient care, understaffing, and misuse of taxpayer funds. The allegations claim patients have suffered and died as a result of the company's practices. Ensign Group's stock fell 8.15% ($13.88 per share) to $156.42 on June 8, 2026, following the report's publication.

Rosen Law Firm has launched an investigation into The Ensign Group, Inc. following a short seller report by Hunterbrook alleging the nursing home operator's business model relies on inadequate patient care, understaffing, and misrouting of taxpayer funds to executives. The allegations claim patients have suffered and died as a result. Ensign shares fell sharply on June 8, 2026, following the report's publication.

The Rosen Law Firm announced an investigation into potential securities claims against The Ensign Group, Inc. following a short seller report by Hunterbrook alleging the nursing home operator's business model relies on inadequate patient care, understaffing, and gaming quality metrics. The allegations claim patients have suffered and died as a result, and that profits depend on routing taxpayer dollars to executives and affiliates. Ensign shares fell sharply on June 8, 2026 following the report's publication.

Block & Leviton is investigating The Ensign Group, Inc. for potential securities law violations following a Hunterbrook Media report alleging chronic understaffing at nursing facilities, inadequate patient care, document falsification, and improper billing practices. The stock fell over 5% on June 8, 2026. Investors who have lost money are encouraged to contact the firm for potential recovery.

Chicago Rivet & Machine Co. (CVR) announced a temporary suspension of its quarterly cash dividend to redirect capital toward operational efficiencies, meeting production requirements, building its sales pipeline, and long-term growth initiatives. The company is prioritizing investments in production capacity, new product launches, and business development resources.

Penske Automotive Group (NYSE: PAG) announced its 22nd consecutive quarterly dividend increase, raising the quarterly dividend to $1.42 per share, up $0.02 or approximately 1.4%. The dividend is payable June 3, 2026. The company's President Robert H. Kurnick, Jr. stated the increase reflects the company's balanced approach to capital allocation including dividends, share repurchases, and strategic acquisitions.